- Home
- RGNX vs HSDT Comparison
RGNX vs HSDT Comparison
Compare RGNX & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- HSDT
- Stock Information
- Founded
- RGNX 2008
- HSDT N/A
- Country
- RGNX United States
- HSDT United States
- Employees
- RGNX N/A
- HSDT N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RGNX Health Care
- HSDT Health Care
- Exchange
- RGNX Nasdaq
- HSDT Nasdaq
- Market Cap
- RGNX 661.2M
- HSDT 707.6M
- IPO Year
- RGNX 2015
- HSDT N/A
- Fundamental
- Price
- RGNX $12.77
- HSDT $5.94
- Analyst Decision
- RGNX Strong Buy
- HSDT
- Analyst Count
- RGNX 7
- HSDT 0
- Target Price
- RGNX $30.00
- HSDT N/A
- AVG Volume (30 Days)
- RGNX 601.4K
- HSDT 1.3M
- Earning Date
- RGNX 11-06-2025
- HSDT 11-14-2025
- Dividend Yield
- RGNX N/A
- HSDT N/A
- EPS Growth
- RGNX N/A
- HSDT N/A
- EPS
- RGNX N/A
- HSDT N/A
- Revenue
- RGNX $155,782,000.00
- HSDT $295,000.00
- Revenue This Year
- RGNX $198.02
- HSDT N/A
- Revenue Next Year
- RGNX $2.67
- HSDT $75.13
- P/E Ratio
- RGNX N/A
- HSDT N/A
- Revenue Growth
- RGNX 74.95
- HSDT N/A
- 52 Week Low
- RGNX $5.04
- HSDT $5.37
- 52 Week High
- RGNX $13.93
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- RGNX 58.75
- HSDT 34.31
- Support Level
- RGNX $12.66
- HSDT $6.01
- Resistance Level
- RGNX $13.93
- HSDT $7.20
- Average True Range (ATR)
- RGNX 0.72
- HSDT 1.59
- MACD
- RGNX -0.04
- HSDT -0.53
- Stochastic Oscillator
- RGNX 61.82
- HSDT 1.72
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.